Prosecution Insights
Prosecution Insights
7 pending office actions • 6 clients • 7 examiners • 6 art units • 0 of 7 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (57%) |
| §102 only | 1 (14%) |
| §112 only | 1 (14%) |
| No statute on record | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HELM, CARALYNNE E | 1 | 28.8% | +49.6% |
| BERHANU, ETSUB D | 1 | 65.5% | +24.5% |
| TIEN, LUCY MINYU | 1 | 61.3% | +35.6% |
| BECKHARDT, LYNDSEY MARIE | 1 | 28.2% | +48.7% |
| TRUONG, QUANGLONG N | 1 | 78.6% | +23.4% |
| RAVINDRA, KRISHNA NUGGEHALLI | 1 | 72.7% | +3.6% |
| DUTT, ADITI | 1 | 47.4% | +47.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | HELM, CARALYNNE E | 105d overdue |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | HELM, CARALYNNE E | 105d overdue |
| 18557925 | Methods And Devices For Non-Invasive Measuring Of Blood Glucose Using Focused Light Sources | BERHANU, ETSUB D | 88d overdue |
| 18179863 | TINCTURE CONTAINING CANNABINOIDS, METHOD OF USING, AND METHOD OF MAKING THE SAME | TRUONG, QUANGLONG N | 50d overdue |
| 18331443 | BROAD SPECTRUM CANNABINOID AND TERPENE MINERAL SALVE, METHOD OF USING, AND METHOD OF MAKING THE SAME | TIEN, LUCY MINYU | 24d overdue |
| 17676085 | Therapeutic Protein Formulations | DUTT, ADITI | 16d overdue |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | BECKHARDT, LYNDSEY MARIE | 56d |
| Client (Assignee) | Pending OAs |
|---|---|
| Holistic Hemp | 2 |
| Biocorrx | 1 |
| Astellas | 1 |
| UNIVERSITY OF CONNECTICUT | 1 |
| SOUTH CHINA NORMAL UNIVERSITY | 1 |
| Gloriana Therapeutics, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 3791 | 1 |
| 1612 | 1 |
| 1613 | 1 |
| 1636 | 1 |
| 1675 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 18426299 | SUBCUTANEOUS BIODEGRADABLE NALTREXONE IMPLANT AND ACCOMPANYING BEHAVIORAL PROGRAM FOR WEIGHT LOSS IN A PATIENT | Biocorrx | HELM, CARALYNNE E | 1615 | §103 | Final Rejection | 105d overdue | Pending | Jan 29, 2024 |
| 18557925 | Methods And Devices For Non-Invasive Measuring Of Blood Glucose Using Focused Light Sources | Astellar Labs, Lnc. | BERHANU, ETSUB D | 3791 | §103 | Non-Final OA | 88d overdue | Pending | Oct 27, 2023 |
| 18331443 | BROAD SPECTRUM CANNABINOID AND TERPENE MINERAL SALVE, METHOD OF USING, AND METHOD OF MAKING THE SAME | Holistic Hemp Solutions, Inc. | TIEN, LUCY MINYU | 1612 | §103 | Final Rejection | 24d overdue | Pending | Jun 08, 2023 |
| 18248021 | NANOMATERIAL AND METHODS OF USE THEREOF | UNIVERSITY OF CONNECTICUT | BECKHARDT, LYNDSEY MARIE | 1613 | Other | Final Rejection | 56d | Pending | Apr 05, 2023 |
| 18179863 | TINCTURE CONTAINING CANNABINOIDS, METHOD OF USING, AND METHOD OF MAKING THE SAME | Holistic Hemp Solutions, Inc. | TRUONG, QUANGLONG N | 1615 | §103 | Non-Final OA | 50d overdue | Pending | Mar 07, 2023 |
| 18096538 | miRNA, and Derivative Thereof and Use Thereof | South China Normal University | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | §112 | Non-Final OA | 87d overdue | Pending | Jan 12, 2023 |
| 17676085 | Therapeutic Protein Formulations | Gloriana Therapeutics, Inc. | DUTT, ADITI | 1675 | §102 | Non-Final OA | 16d overdue | Pending | Feb 18, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial